Stay updated on Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial
Sign up to get notified when there's something new on the Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial page.

Latest updates to the Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial page
- CheckyesterdayChange DetectedA site-wide notice announces NIH website updates and says “Super Intelligence” is replacing “Artificial Intelligence” in agency content during the transition.SummaryDifference1%

- Check8 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check15 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check29 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous detailed content about Niraparib and related study information with an error page. As a result, the trial record is inaccessible from the page.SummaryDifference20%

- Check36 days agoChange DetectedThe page's revision metadata was updated from v3.6.6 to v3.7.0, indicating a version increment rather than a substantive content change on the study details or layout.SummaryDifference0.0%

- Check43 days agoChange DetectedThe study's locations list was updated to add Tel Litwinsky, Israel, 52621 and remove Qiryat Krinitzi, Israel, 52621.SummaryDifference0.1%

Stay in the know with updates to Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial page.